$HSTA
Hestia Insight Inc. Stock $hsta

$hsta Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000182912624007279 Filed on November 04, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue		$33.53K	$45.00K
YoY Change		-25.49%
Cost Of Revenue
YoY Change
Gross Profit		$33.53K	$45.00K
YoY Change		-25.49%
Gross Profit Margin		100.0%	100.0%
Selling, General & Admin		$20.72K	$92.87K
YoY Change		-77.69%	41.35%
% of Gross Profit		61.79%	206.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$0.00
YoY Change			-100.0%
% of Gross Profit			0.0%
Operating Expenses		$20.72K	$92.87K
YoY Change		-77.69%	41.35%
Operating Profit		-$12.81K	-$47.87K
YoY Change		-73.23%	-27.14%
Interest Expense		$1.787K
YoY Change
% of Operating Profit
Other Income/Expense, Net		-$448.3K	-$90.38K
YoY Change		396.02%	-128.41%
Pretax Income		-$435.5K	-$138.2K
YoY Change		215.01%	-154.77%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$435.5K	-$138.2K
YoY Change		215.01%	-154.77%
Net Earnings / Revenue		-1298.86%	-307.22%
Basic Earnings Per Share		-$0.02	$0.00
Diluted Earnings Per Share		-$0.02	$0.00
COMMON SHARES
Basic Shares Outstanding	27.94M shares	27.94M shares	27.94M shares
Diluted Shares Outstanding			27.94M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$260.0K
YoY Change		-68.0%
Cash & Equivalents	$56.63K	$165.6K
Short-Term Investments		$90.00K
Other Short-Term Assets		$0.00
YoY Change		-100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.036M	$257.4K
YoY Change	302.38%	-69.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.81K	$29.91K
YoY Change	-20.41%	-71.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$930.0K	$91.83K
YoY Change	912.71%	-81.18%
Other Assets
YoY Change
Total Long-Term Assets	$23.81K	$29.91K
YoY Change	-20.41%	-79.75%
TOTAL ASSETS
Total Short-Term Assets	$1.036M	$257.4K
Total Long-Term Assets	$23.81K	$29.91K
Total Assets	$1.060M	$287.4K
YoY Change	268.79%	-71.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$30.00K
YoY Change		792.86%
Accrued Expenses		$0.00
YoY Change		-100.0%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$108.5K	$34.19K
YoY Change	217.35%	20.39%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$108.5K	$34.19K
Total Long-Term Liabilities		$0.00
Total Liabilities	$108.5K	$34.19K
YoY Change	217.35%	15.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$43.43K	-$681.5K
YoY Change	-93.63%	-2297.56%
Common Stock	$27.94K	$27.94K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$951.2K	$253.2K
YoY Change
Total Liabilities & Shareholders Equity	$1.060M	$287.4K
YoY Change	268.79%	-71.13%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	-$435.5K	-$138.2K
YoY Change	215.01%	-154.77%
Depreciation, Depletion And Amortization		$0.00
YoY Change		-100.0%
Cash From Operating Activities		-$30.00K
YoY Change		-59.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$40.00K
YoY Change		-18.52%
Cash From Investing Activities		$40.00K
YoY Change		-18.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities		-30.00K
Cash From Investing Activities		40.00K
Cash From Financing Activities		0.000
Net Change In Cash		10.00K
YoY Change		-108.06%
FREE CASH FLOW
Cash From Operating Activities		-$30.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	us-gaap	Revenues Revenues	33529	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--11-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001813603
CY2023Q3	HSTA	Cost Of Revenues CostOfRevenues		usd
	HSTA	Cost Of Revenues CostOfRevenues		usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-08-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	024-11289
	dei	Entity Registrant Name EntityRegistrantName	HESTIA INSIGHT INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-0994055
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 S. 4th Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89101
	dei	City Area Code CityAreaCode	(702)
	dei	Local Phone Number LocalPhoneNumber	793-4028
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	93890	usd
CY2024Q3	us-gaap	Investments Investments	929954	usd
CY2023Q4	us-gaap	Investments Investments	73006	usd
CY2024Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	49340	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27422	usd
CY2023Q4	us-gaap	Assets Assets	194338	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16214	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16214	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	194338	usd
CY2023Q3	HSTA	Consulting Revenue ConsultingRevenue	45000	usd
	HSTA	Consulting Revenue ConsultingRevenue	1312930	usd
	HSTA	Consulting Revenue ConsultingRevenue	75500	usd
CY2023Q3	us-gaap	Revenues Revenues	45000	usd
	us-gaap	Revenues Revenues	1312930	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent		usd
CY2023Q4	HSTA	Charger Gogo Machines ChargerGogoMachines		usd
CY2023Q4	HSTA	Related Party Note Payable RelatedPartyNotePayable		usd
CY2024Q3	HSTA	Cost Of Revenues CostOfRevenues		usd
	HSTA	Cost Of Revenues CostOfRevenues		usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2024Q3	HSTA	Bad Debt Expenses BadDebtExpenses		usd
CY2023Q3	HSTA	Bad Debt Expenses BadDebtExpenses		usd
	HSTA	Bad Debt Expenses BadDebtExpenses		usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Capital Leases Net GainLossOnSaleOfCapitalLeasesNet		usd
	us-gaap	Gain Loss On Sale Of Capital Leases Net GainLossOnSaleOfCapitalLeasesNet		usd
CY2023Q3	us-gaap	Interest Expense InterestExpense		usd
	us-gaap	Interest Expense InterestExpense		usd
CY2024Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2024Q3	HSTA	Utilization Of Net Operating Loss Carryforward UtilizationOfNetOperatingLossCarryforward		usd
CY2023Q3	HSTA	Utilization Of Net Operating Loss Carryforward UtilizationOfNetOperatingLossCarryforward		usd
	HSTA	Utilization Of Net Operating Loss Carryforward UtilizationOfNetOperatingLossCarryforward		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	HSTA	Realized Loss On Sale Of Capital Assets RealizedLossOnSaleOfCapitalAssets		usd
	HSTA	Equity Securities Received For Consulting Fees EquitySecuritiesReceivedForConsultingFees		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	HSTA	Bad Debt Expense BadDebtExpense		usd
	HSTA	Increase Decrease In Credit Card Payable IncreaseDecreaseInCreditCardPayable		usd
	HSTA	Dividend Income And Interest Income DividendIncomeAndInterestIncome		usd
	HSTA	Proceeds Used In Purchase Of Vending Machines ProceedsUsedInPurchaseOfVendingMachines		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments		usd
	HSTA	Proceeds Provided By Related Party Loan ProceedsProvidedByRelatedPartyLoan		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
	HSTA	Investment In Equities Cumulative Impairments InvestmentInEquitiesCumulativeImpairments		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	27939260	shares
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	56633	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	1035928	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	166896	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10147	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6510	usd
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9602	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	27442	usd
CY2024Q3	HSTA	Charger Gogo Machines ChargerGogoMachines	14203	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23805	usd
CY2024Q3	us-gaap	Assets Assets	1059733	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	29575	usd
CY2024Q3	HSTA	Related Party Note Payable RelatedPartyNotePayable	78931	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	108506	usd
CY2024Q3	us-gaap	Liabilities Liabilities	108506	usd
CY2023Q4	us-gaap	Liabilities Liabilities	16214	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	285000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	285000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27939260	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27939260	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27939260	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27939260	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	27939	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	27939	usd
CY2024Q3	HSTA	Cancelled Shares Shares CancelledSharesShares	5100000	shares
CY2023Q4	HSTA	Cancelled Shares Shares CancelledSharesShares	5100000	shares
CY2024Q3	HSTA	Cancelled Shares Value CancelledSharesValue	5100	usd
CY2023Q4	HSTA	Cancelled Shares Value CancelledSharesValue	5100	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	961613	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	901613	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43425	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-756528	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	951227	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	178124	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1059733	usd
CY2024Q3	HSTA	Consulting Revenue ConsultingRevenue	33529	usd
	us-gaap	Revenues Revenues	75500	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	33529	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	45000	usd
	us-gaap	Gross Profit GrossProfit	1312930	usd
	us-gaap	Gross Profit GrossProfit	75500	usd
	HSTA	Bad Debt Expenses BadDebtExpenses	5185	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20717	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	92867	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	189056	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	319802	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	20717	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	92867	usd
	us-gaap	Operating Expenses OperatingExpenses	189056	usd
	us-gaap	Operating Expenses OperatingExpenses	324987	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12812	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-47867	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1123874	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-249487	usd
CY2024Q3	us-gaap	Interest Income Operating InterestIncomeOperating	600	usd
CY2023Q3	us-gaap	Interest Income Operating InterestIncomeOperating	900	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	2625	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	2550	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Capital Leases Net GainLossOnSaleOfCapitalLeasesNet	-49656	usd
	us-gaap	Gain Loss On Sale Of Capital Leases Net GainLossOnSaleOfCapitalLeasesNet	-74889	usd
CY2024Q3	HSTA	Change In Fair Value Of Equity Securities ChangeInFairValueOfEquitySecurities	443207	usd
CY2023Q3	HSTA	Change In Fair Value Of Equity Securities ChangeInFairValueOfEquitySecurities	41624	usd
	HSTA	Change In Fair Value Of Equity Securities ChangeInFairValueOfEquitySecurities	409653	usd
	HSTA	Change In Fair Value Of Equity Securities ChangeInFairValueOfEquitySecurities	103537	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	1787	usd
	us-gaap	Interest Expense InterestExpense	3743	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-448306	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-90380	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-410771	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-175876	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-435494	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-138247	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	713103	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-425363	usd
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	149752	usd
	HSTA	Utilization Of Net Operating Loss Carryforward UtilizationOfNetOperatingLossCarryforward	-149752	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	-435494	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-138247	usd
	us-gaap	Profit Loss ProfitLoss	713103	usd
	us-gaap	Profit Loss ProfitLoss	-425363	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2024Q3	HSTA	Ave.Common Shares Outstanding Basic And Diluted Ave.CommonSharesOutstandingBasicAndDiluted	27939260	shares
CY2023Q3	HSTA	Ave.Common Shares Outstanding Basic And Diluted Ave.CommonSharesOutstandingBasicAndDiluted	27939260	shares
	HSTA	Ave.Common Shares Outstanding Basic And Diluted Ave.CommonSharesOutstandingBasicAndDiluted	27939260	shares
	HSTA	Ave.Common Shares Outstanding Basic And Diluted Ave.CommonSharesOutstandingBasicAndDiluted	27939260	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	678529	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-153913	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	524616	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-119811	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	404805	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-138247	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	266558	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	178124	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-24699	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	153425	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	1173296	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1326721	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-435494	usd
CY2024Q3	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	60000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	951227	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	713103	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-425363	usd
	HSTA	Realized Loss On Sale Of Capital Assets RealizedLossOnSaleOfCapitalAssets	74889	usd
	HSTA	Equity Securities Received For Consulting Fees EquitySecuritiesReceivedForConsultingFees	1265484	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-409653	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-103537	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	60000	usd
	us-gaap	Depreciation Depreciation	3637	usd
	us-gaap	Depreciation Depreciation	12021	usd
	HSTA	Bad Debt Expense BadDebtExpense	5185	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	49340	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23248	usd
	HSTA	Increase Decrease In Credit Card Payable IncreaseDecreaseInCreditCardPayable	9618	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-118813	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-206483	usd
	HSTA	Dividend Income And Interest Income DividendIncomeAndInterestIncome	2625	usd
	HSTA	Proceeds Used In Purchase Of Vending Machines ProceedsUsedInPurchaseOfVendingMachines	385	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	46000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	30125	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	103658	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2625	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	119148	usd
	HSTA	Proceeds Provided By Related Party Loan ProceedsProvidedByRelatedPartyLoan	78931	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78931	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-37257	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-87335	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	93890	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	252956	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	56633	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	165621	usd
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zGLCyACx1u0b" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_866_zSjPurWYeIIc">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements are prepared on the basis of accounting principles generally accepted in the United States of America, also referred to as U.S. GAAP. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the dates of the balance sheets and the income and expenses for the periods ended as stated in the statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q3	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1342394	usd
	us-gaap	Increase Decrease In Equity Securities Fv Ni IncreaseDecreaseInEquitySecuritiesFvNi	-360569	usd
	HSTA	Investment In Equities Cumulative Fair Value Adjustment InvestmentInEquitiesCumulativeFairValueAdjustment	-412465	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	929954	usd
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	3930	usd
CY2024Q3	HSTA	Lines Of Credit Receivable LinesOfCreditReceivable	0	usd
CY2023Q4	HSTA	Lines Of Credit Receivable LinesOfCreditReceivable	0	usd
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	HSTA	Preferred Stock Cancelled PreferredStockCancelled	10000000	shares
	HSTA	Schedule Of Fair Value Measurements Rollforward Table Textablock ScheduleOfFairValueMeasurementsRollforwardTableTextablock	<table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--ScheduleOfFairValueMeasurementsRollforwardTableTextablock_z7z25zKGs5x9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Options to Acquire Common Stock (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top"> <span id="xdx_8BF_zT5g2oxmd6q6" style="display: none">Schedule Of Fair Value Measurements Rollforward</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Low</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">High</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; width: 76%; padding-bottom: 1pt; vertical-align: top">Rate</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20231201__20240831__srt--RangeAxis__srt--MinimumMember_ztznu5OCRJL6" title="Rate">4.01</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20231201__20240831__srt--RangeAxis__srt--MaximumMember_zdXeA07WNpqi" title="Rate">4.01</span></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top">Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20231201__20240831__srt--RangeAxis__srt--MinimumMember_z4idsEt3s4Me" title="Volatility">195.43</span></td><td style="padding-bottom: 1pt; text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20231201__20240831__srt--RangeAxis__srt--MaximumMember_zJiY63OUL0X" title="Volatility">195.43</span></td><td style="padding-bottom: 1pt; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top">Stock price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharePrice_iI_c20240831__srt--RangeAxis__srt--MinimumMember_zkpqjPI12yc" style="text-align: right" title="Stock price">0.16</td><td style="padding-bottom: 1pt; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SharePrice_iI_c20240831__srt--RangeAxis__srt--MaximumMember_zm4IdPZmTOnc" style="text-align: right" title="Stock price">0.16</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; vertical-align: top">Exercise price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240831__srt--RangeAxis__srt--MinimumMember_zMOtXpLzhsXi" style="text-align: right" title="Exercise price">0.20</td><td style="padding-bottom: 1pt; text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20240831__srt--RangeAxis__srt--MaximumMember_zBPpsbn4bn02" style="text-align: right" title="Exercise price">0.20</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1pt">Term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231201__20240831__srt--RangeAxis__srt--MinimumMember_z6B4IXipaaNl" title="Term (years)">3.00</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20231201__20240831__srt--RangeAxis__srt--MaximumMember_zlnByTfu5uNb" title="Term (years)">3.00</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	80000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.06
	HSTA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P2Y6M7D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1500000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.20
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y9M25D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1580000	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
	HSTA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P4Y8M12D

Files In Submission

Name	View Source	Status
0001829126-24-007279-index-headers.html	Edgar Link	pending
0001829126-24-007279-index.html	Edgar Link	pending
0001829126-24-007279.txt	Edgar Link	pending
0001829126-24-007279-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hestialnsightinc_10q.htm	Edgar Link	pending
hestialnsightinc_ex31-1.htm	Edgar Link	pending
hestialnsightinc_ex31-2.htm	Edgar Link	pending
hestialnsightinc_ex32.htm	Edgar Link	pending
hsta-20240831.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
hsta-20240831_cal.xml	Edgar Link	unprocessable
hsta-20240831_def.xml	Edgar Link	unprocessable
hsta-20240831_lab.xml	Edgar Link	unprocessable
hsta-20240831_pre.xml	Edgar Link	unprocessable
hestialnsightinc_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HSTA
Hestia Insight Inc. Stock $hsta

2024 Q4 Form 10-Q Financial Statement

#000182912624007279 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTA Hestia Insight Inc. Stock $hsta

2024 Q4 Form 10-Q Financial Statement

#000182912624007279 Filed on November 04, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HSTA
Hestia Insight Inc. Stock $hsta